🇺🇸 FDA
Patent

US 8974801

Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate

granted A61KA61K31/663A61K33/42

Quick answer

US patent 8974801 (Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate) held by Amphastar Pharmaceuticals, Inc. expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Amphastar Pharmaceuticals, Inc.
Grant date
Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/663, A61K33/42, A61K9/0019, A61K9/10